Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abman, S H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abman, S H
Archives of Disease in Childhood Fetal and Neonatal Edition 2002;87:F15-F18
© 2002 Archives of Disease in Childhood Fetal and Neonatal Edition


SYMPOSIUM

Monitoring cardiovascular function in infants with chronic lung disease of prematurity

S H Abman

Correspondence to:
Correspondence to:
Professor Abman, Department of Pediatrics, B-395, The Children's Hospital, 1056 E Nineteenth Avenue, Denver, CO 80218, USA;
steven.abman{at}uchsc.edu.


ABSTRACT
In addition to persistent airways disease, survivors of premature birth with chronic lung disease are at risk of cardiovascular sequelae, including pulmonary hypertension, systemic hypertension, left ventricular hypertrophy, and exercise intolerance. The major treatment of pulmonary hypertension is supplemental oxygen, but drugs such as calcium channel blockers may also be required. The use of inhaled nitric oxide for its long term management is being investigated


Keywords: chronic lung disease; premature; cardiovascular function; pulmonary hypertension

Abbreviations: CLD, chronic lung disease; BPD, bronchopulmonary dysplasia; RDS, respiratory distress syndrome; PVR, pulmonary vascular resistance; iNO, inhaled nitric oxide; LVH, left ventricular hypertrophy; ECG, electrocardiogram




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
C. D. Fike, Y. Zhang, and M. R. Kaplowitz
Thromboxane inhibition reduces an early stage of chronic hypoxia-induced pulmonary hypertension in piglets
J Appl Physiol, August 1, 2005; 99(2): 670 - 676.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. C. McCurnin, R. A. Pierce, L. Y. Chang, L. L. Gibson, S. Osborne-Lawrence, B. A. Yoder, J. D. Kerecman, K. H. Albertine, V. T. Winter, J. J. Coalson, et al.
Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease
Am J Physiol Lung Cell Mol Physiol, March 1, 2005; 288(3): L450 - L459.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. M. Mourani, D. D. Ivy, D. Gao, and S. H. Abman
Pulmonary Vascular Effects of Inhaled Nitric Oxide and Oxygen Tension in Bronchopulmonary Dysplasia
Am. J. Respir. Crit. Care Med., November 1, 2004; 170(9): 1006 - 1013.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health